Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Hydrocortisone for Post-Anesthesia Sore Throat
IRCT20251231068511N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of hydrocortisone in Post-extubation sore throat (POST), sponsored by Zahedan University of Medical Sciences. Started Jun 2026; status: completed.
02
Drugs
hydrocortisone
03
Conditions
Post-extubation sore throat (POST)
Beyond the preview
Go deeper on IRCT20251231068511N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251231068511N1.